| Quarterly Financials | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 1 | 6 | 5 | 5 | 5 | 5 | 7 | 12 | 6 |
| Expenses | 0 | 1 | 1 | 9 | 2 | 2 | 1 | 3 | 11 | 8 | 8 | 8 | 9 | 12 | 14 | 8 |
| EBITDA | -0 | -1 | -1 | -9 | -1 | -1 | -1 | -2 | -6 | -4 | -2 | -3 | -4 | -5 | -2 | -3 |
| Operating Profit % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | -12,200 % | -96 % | -74 % | -46 % | -62 % | -82 % | -81 % | -62 % | -53 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | -0 | -1 | -1 | -9 | -1 | -1 | -1 | -2 | -7 | -4 | -3 | -4 | -5 | -7 | -4 | -4 |
| Tax | 0 | 0 | 0 | -2 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -1 | -1 |
| Net Profit | -0 | -1 | -1 | -6 | -1 | -1 | -1 | -1 | -6 | -3 | -2 | -3 | -5 | -5 | -3 | -3 |
| EPS in ₹ | 0.00 | -0.05 | -0.54 | -4.76 | -0.61 | -0.61 | -0.24 | -0.54 | -2.82 | -0.76 | -0.73 | -0.55 | -1.11 | -1.39 | -0.70 | -0.70 |
Pharmaids Pharmaceuticals
Pharmaids Pharmaceuticals
35.03
+0.08
(0.23%)
Market Cap
123.58 Cr
PE Ratio
-8.05
Volume
48,676.00
Day High - Low
36.50 - 30.56
52W High-Low
75.98 - 34.00
Key Fundamentals
Market Cap
123.58 Cr
EPS
-3.05
PE Ratio
-8.05
PB Ratio
2.37
Book Value
16.38
EBITDA
-12.70
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
-24.54
Debt to Equity
0.36
Actual
Company News
View All News
Pharmaids Pharmaceuticals has scheduled a board meeting on February 12, 2026, to consider and approve unaudited financial results for Q3FY26 and nine months ended December 31, 2025.
Pharmaids Independent Director Completes Term
Jan 05, 2026
Jan 05, 2026Pharmaids Pharmaceuticals announces completion of Mr. Mopperthy Sudheer's independent directorship term effective January 05, 2026, leading to his cessation from board committees.
Pharmaids Pharma Reconstitutes Board CommitteesJan 05, 2026
Jan 05, 2026Pharmaids Pharmaceuticals Limited announces reconstitution of Audit Committee and Nomination & Remuneration Committee effective January 06, 2026, with new leadership structure.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,724.40 | #1 4,13,741.32 | 37.53 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 58.16 | |
6,291.00 | 1,67,006.28 | 67.40 | 9,712.00 | 18.67 | 2,191 | -1.02 | 53.89 | |
4,241.70 | 1,43,558.40 | 62.90 | 11,539.40 | 6.99 | 1,911 | 26.24 | 66.58 | |
1,341.10 | 1,08,330.28 | 23.68 | 28,409.50 | 7.12 | 5,291 | -57.18 | 43.41 | |
1,280.40 | 1,06,866.07 | 19.34 | 33,741.20 | 16.73 | 5,725 | -15.28 | 60.10 | |
2,219.40 | 1,01,381.93 | 21.81 | 22,909.50 | 13.74 | 3,306 | #1 37.44 | 57.52 | |
900.75 | 90,636.53 | #1 18.06 | 23,511.00 | 18.55 | 4,615 | -0.32 | 49.52 | |
2,024.30 | 83,564.13 | 46.65 | 12,744.20 | #1 20.90 | 2,007 | 7.65 | 38.95 | |
1,158.80 | 67,303.29 | 19.60 | 32,345.60 | 9.43 | 3,484 | 7.59 | 47.48 | |
5,392.00 | 64,469.45 | 26.53 | 13,458.30 | 3.70 | 2,216 | 1.90 | 37.57 |
Growth Rate
Revenue Growth
22.50 %
Net Income Growth
14.41 %
Cash Flow Change
-31.73 %
ROE
46.07 %
ROCE
-5.39 %
EBITDA Margin (Avg.)
-10.09 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 11 | 25 | 91 | 120 |
| Fixed Assets | 0 | 0 | 63 | 77 |
| Current Assets | 3 | 18 | 14 | 22 |
| Capital Work in Progress | 0 | 2 | 7 | 5 |
| Investments | 0 | 3 | 0 | 0 |
| Other Assets | 11 | 19 | 21 | 39 |
| Total Liabilities | 11 | 25 | 91 | 120 |
| Current Liabilities | 2 | 2 | 12 | 29 |
| Non Current Liabilities | 0 | 0 | 9 | 36 |
| Total Equity | 9 | 23 | 71 | 55 |
| Reserve & Surplus | -2 | 1 | 37 | 24 |
| Share Capital | 10 | 21 | 35 | 35 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 12 | -8 | -3 |
| Investing Activities | 1 | -5 | -75 | -12 |
| Operating Activities | -0 | -4 | -11 | -14 |
| Financing Activities | 0 | 21 | 78 | 23 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Jan 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Apr 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 65.81 % | 65.80 % | 65.65 % | 55.56 % | 35.44 % | 20.70 % | 21.08 % | 16.54 % | 16.45 % | 9.95 % | 9.94 % | 9.70 % | 9.25 % | 5.64 % | 5.64 % | 5.56 % | 5.19 % | 5.22 % | 5.22 % | 5.14 % | 32.99 % | 32.99 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 33.44 % | 33.19 % | 33.70 % | 43.47 % | 63.98 % | 78.72 % | 74.07 % | 69.78 % | 69.87 % | 81.71 % | 81.27 % | 81.93 % | 60.78 % | 41.06 % | 41.06 % | 41.14 % | 41.03 % | 36.42 % | 36.59 % | 36.35 % | 47.02 % | 47.24 % |
| Others | 0.74 % | 1.01 % | 0.65 % | 0.97 % | 0.58 % | 0.57 % | 4.84 % | 13.68 % | 13.68 % | 8.34 % | 8.79 % | 8.37 % | 29.96 % | 53.30 % | 53.30 % | 53.29 % | 53.78 % | 58.37 % | 58.20 % | 58.51 % | 19.99 % | 19.77 % |
| No of Share Holders | 5,861 | 7,192 | 7,331 | 8,314 | 9,620 | 9,495 | 9,193 | 8,862 | 8,196 | 7,761 | 7,476 | 7,393 | 7,281 | 7,554 | 7,567 | 7,594 | 8,050 | 8,349 | 8,220 | 8,026 | 8,027 | 8,288 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 31 Dec 2022 |  Extraordinary General Meeting | NA | 31 Dec 2022 | 18.95 | 28.00 |
| 31 Jan 2024 | Extraordinary General Meeting | NA | 31 Jan 2024 | 62.10 | 61.02 |
| 25 Sept 2024 |  Annual General Meeting | NA | 25 Sept 2024 | 45.34 | 39.89 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 68.56 | 83.30 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 73.59 | 68.30 |
| 23 May 2025 | Quarterly Result Announcement | NA | 23 May 2025 | 67.93 | 67.72 |
| 07 Aug 2025 | Quarterly Result Announcement | NA | 07 Aug 2025 | 63.22 | 63.49 |
| 21 Aug 2025 | Quarterly Result Announcement | NA | 21 Aug 2025 | 62.15 | 62.15 |
| 23 Sept 2025 | Annual General Meeting | NA | 23 Sept 2025 | 59.54 | 56.95 |
| 11 Nov 2025 | Quarterly Result Announcement | NA | 11 Nov 2025 | 48.21 | 48.42 |
| 12 Feb 2026 | Quarterly Result Announcement | NA | 12 Feb 2026 | 39.22 | 38.95 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication6 days ago
6 days agoReport Of Auditors On Financial Results For The Quarter And Nine Months Ended December 31 2025 With UDIN8 days ago
8 days agoUnaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.8 days ago
8 days agoBoard Meeting Outcome for Outcome Of The Board Meeting.8 days ago
8 days agoBoard Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2025.Feb 09, 2026
Feb 09, 2026Re-Lodgement Of Requests For Transfer Of Physical SharesJan 16, 2026
Jan 16, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Jan 12, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJan 05, 2026
Jan 05, 2026Outcome Of The Circular Resolution Dated 05Th January 2026.Jan 05, 2026
Jan 05, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJan 02, 2026
Jan 02, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 02, 2026
Jan 02, 2026Closure of Trading WindowDec 30, 2025
Dec 30, 2025Re-Lodgment Of Requests For Transfer Of Physical SharesDec 12, 2025
Dec 12, 2025Announcement under Regulation 30 (LODR)-Change in ManagementDec 10, 2025
Dec 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 30, 2025
Nov 30, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotNov 29, 2025
Nov 29, 2025Announcement under Regulation 30 (LODR)-Change in ManagementNov 28, 2025
Nov 28, 2025Outcome Of The Circular Resolution Dated 28Th November 2025.Nov 28, 2025
Nov 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2025
Nov 13, 2025Re-Lodgement Of Requests For Transfer Of Physical SharesNov 12, 2025
Nov 12, 2025 Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.Nov 11, 2025
Nov 11, 2025Board Meeting Outcome for Outcome Of The Board MeetingNov 11, 2025
Nov 11, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025.Nov 06, 2025
Nov 06, 2025Re-Lodgement Of Requests For Transfer Of Physical SharesOct 15, 2025
Oct 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Closure of Trading WindowSep 30, 2025
Sep 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 24, 2025
Sep 24, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 24, 2025
Sep 24, 2025Intimation Under Regulation 31A(10)(Ii) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Reclassification Of Promoter(S) Pursuant To The Open Offer Under SEBI (SAST) Regulations 2011.Sep 24, 2025
Sep 24, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 23, 2025
Sep 23, 2025Announcement under Regulation 30 (LODR)-Diversification / DisinvestmentSep 18, 2025
Sep 18, 2025Announcement Under Regulation 30 - Intimation Of Registration Of Sale Deed.Sep 06, 2025
Sep 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2025
Aug 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2025
Aug 30, 2025Reg. 34 (1) Annual Report.Aug 29, 2025
Aug 29, 2025Notice Of Convening The 36Th Annual General MeetingAug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Open Offer - UpdatesAug 29, 2025
Aug 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 29, 2025
Aug 29, 2025Post Offer AdvertisementAug 29, 2025
Aug 29, 2025Announcement Under Reg 30(LODR) - Appointment Of Secretarial AuditorAug 21, 2025
Aug 21, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On August 21 2025.Aug 21, 2025
Aug 21, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 21, 2025
Aug 21, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAug 18, 2025
Aug 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Aug 09, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)Aug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 07, 2025
Aug 07, 2025Unaudited Financial Results For The Quarter Ended June 30 2025.Aug 07, 2025
Aug 07, 2025Board Meeting Outcome for Outcome Of The Board Meeting Dated August 07 2025.Aug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Open Offer - UpdatesAug 07, 2025
Aug 07, 2025Technical Indicators
RSI(14)
Neutral 29.26
ATR(14)
Volatile 3.31
STOCH(9,6)
Oversold 19.56
STOCH RSI(14)
Oversold 7.75
MACD(12,26)
Bearish -0.33
ADX(14)
Strong Trend 28.10
UO(9)
Bearish 45.61
ROC(12)
Downtrend And Accelerating -16.34
WillR(14)
Neutral -66.74
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
